Follow Us:

CE MARKING

Home Class 3 Medical Device

Class III Medical Device (Class 3) under EU MDR

A Class III medical device is in the highest risk class under EU MDR 2017/745. Annex VIII places a device in Class III when it is in direct contact with the heart, central circulatory system or central nervous system, is an active implant, contains an ancillary medicinal substance, or meets another high-risk rule. Every Class III device needs a Notified Body for CE marking, and most need a clinical investigation under Article 61(4).

Key facts: Risk class: highest of four (I, IIa, IIb, III). Classification: Annex VIII, where 12 of the 22 rules can lead to Class III. Conformity assessment: Annex IX, or Annex X with Annex XI (Article 52(3)). Clinical evidence: clinical investigation normally required; SSCP and annual PSUR mandatory.

Classification rules

Which Rules Make a Device Class III?

Class III comes from applying the 22 rules in Annex VIII of the MDR to the device’s intended purpose. If more than one rule applies, the strictest rule decides the class. The table lists the rules that lead to Class III. See all 22 rules on the medical device classification page. The European Commission guidance MDCG 2021-24 explains how to apply the rules.

Annex VIII rules that lead to Class III

RuleWhen the device is Class III
Rule 3Non-invasive devices made of a substance used in vitro in direct contact with human cells, tissues, organs or embryos before they are implanted or administered
Rule 6Transient surgically invasive devices that control, diagnose, monitor or correct a defect of the heart or central circulatory system through direct contact, or that are in direct contact with the heart, central circulatory system or central nervous system
Rule 7Short-term surgically invasive devices in direct contact with the heart, central circulatory system or central nervous system, or that have a biological effect or are wholly or mainly absorbed
Rule 8Implantable and long-term surgically invasive devices in direct contact with the heart, central circulatory system or central nervous system; active implantables and their accessories; breast implants; surgical meshes; total and partial joint replacements; spinal disc replacements and implants in contact with the spinal column; devices with a biological effect, wholly or mainly absorbed, that undergo chemical change in the body (except in the teeth) or that administer medicines
Rule 9Active devices that control, monitor or directly influence the performance of active implantable devices
Rule 11Software providing information used for decisions that may cause death or an irreversible deterioration of health
Rule 14Devices that include, as an integral part, a medicinal substance with an ancillary action, including a human blood or plasma derivative
Rule 15Contraception or STD-prevention devices that are implantable or long-term invasive
Rule 18Devices made with non-viable human or animal tissues or cells, or their derivatives (except animal-tissue devices for contact with intact skin only)
Rule 19Devices containing nanomaterial with high or medium potential for internal exposure
Rule 21Substances introduced into the body that are systemically absorbed to achieve their purpose, or that act in the stomach or lower gastrointestinal tract and are systemically absorbed
Rule 22Active therapeutic devices with an integrated diagnostic function that significantly determines patient management, such as closed-loop systems and automated external defibrillators

Software and accessories

Software that drives or influences a device falls into the same class as the device. Accessories are classified in their own right (Annex VIII, implementing rules 3.3 and 3.2).

Examples

What Are Examples of Class III Medical Devices?

The examples below are typical. The class of your device always depends on its intended purpose and claims, so confirm the rule for your own product.

DeviceRuleWhy it is Class III
Prosthetic heart valveRule 8Implant in direct contact with the heart
Coronary stentRule 8Implant in direct contact with the central circulatory system
Drug-eluting stentRules 8 and 14Implant in the circulatory system with an ancillary medicinal substance
Implantable pacemaker or neurostimulatorRule 8Active implantable device
Pacemaker programmerRule 9Active device that controls an active implantable device
Hip or knee joint replacementRule 8Total or partial joint replacement
Spinal disc replacementRule 8Implant in contact with the spinal column
Breast implantRule 8Named in Rule 8
Surgical meshRule 8Named in Rule 8
Absorbable sutureRule 8Long-term implant that is wholly or mainly absorbed
Collagen or bovine-tissue implantRule 18Made from non-viable animal tissue
IVF culture mediaRule 3In direct contact with human embryos before implantation
Automated external defibrillatorRule 22Integrated diagnosis that decides the therapy

Note: the ancillary screws, wedges, plates and instruments used with joint and spinal implants are not automatically Class III. Classify each component on its own.

CE marking

How Do You CE Mark a Class III Device?

A Class III device cannot be self-certified. Article 52(3) gives two conformity assessment routes, and both involve a Notified Body.

Route 1: Annex IX

Full quality management system assessment (Chapter I), assessment of the technical documentation of every device (Chapter II), and ongoing surveillance audits (Chapter I, Section 3).

Route 2: Annex X with Annex XI

EU type-examination of a representative sample (Annex X), followed by production quality assurance or product verification (Annex XI).

Class III medical device conformity assessment routes under EU MDR: Annex IX, or Annex X with Annex XI
Figure: the two Class III conformity assessment routes under Article 52(3) of EU MDR 2017/745.
  1. Confirm the class and ruleRecord the Annex VIII rule and your reasoning in the technical documentation.
  2. Set up the QMSImplement an MDR quality management system, usually to EN ISO 13485, with risk management to EN ISO 14971. Software devices also follow IEC 62304, and clinical investigations follow ISO 14155.
  3. Build the clinical evidencePlan the clinical evaluation and the clinical investigation required by Article 61(4), unless a justified exemption applies.
  4. Prepare the technical documentationCompile the technical documentation: Annex II and Annex III files, including GSPR checklist, verification and validation, labelling and the PMS plan.
  5. Notified Body reviewThe Notified Body (listed in the European Commission NANDO database) audits the QMS and reviews the technical documentation. For implantable Class III devices it also runs the clinical evaluation consultation procedure.
  6. CE certificate, declaration and registrationSign the EU declaration of conformity, affix the CE mark with the Notified Body number, and register the device and UDI in EUDAMED (mandatory since 28 May 2026).

Clinical evaluation consultation procedure (CECP): under Article 54, the Notified Body sends its clinical evaluation assessment report for Class III implantable devices to an expert panel. The panel may give a scientific opinion, and the Notified Body must give due consideration to it before issuing the certificate.

The consultation is not required for certificate renewals, for modifications of a device the same manufacturer already markets for the same intended purpose, or where common specifications for the clinical evaluation of that device type exist (Article 54(2)).

Documentation

What Technical Documentation and Clinical Evidence Does Class III Need?

All devices need technical documentation and a clinical evaluation. For Class III, the Notified Body checks the evidence for each device, and several extra documents apply.

Clinical investigation

Article 61(4) requires clinical investigations for implantable and Class III devices. Exemptions are narrow, for example some device modifications by the same manufacturer and some equivalent devices with full access to data.

Summary of safety and clinical performance

Article 32 requires an SSCP for implantable and Class III devices. The Notified Body validates it and it is published in EUDAMED.

PSUR every year

Article 86 requires a periodic safety update report, updated at least annually for Class IIb and Class III devices. Class III manufacturers submit it to their Notified Body, which reviews it and records its evaluation. Submission will move to EUDAMED once the vigilance and post-market surveillance module becomes mandatory; as of November 2026 it is not.

Implant card

Article 18 requires an implant card and patient information for implantable Class III devices. Non-implantable Class III devices do not need one. Sutures, staples, dental fillings, dental braces, tooth crowns, screws, wedges, plates, wires, pins, clips and connectors are exempt.

PMCF

A post-market clinical follow-up plan and report keep the clinical evidence current throughout the device’s life.

UDI

Class III and implantable devices have carried the UDI on their labels since 26 May 2021.

Other obligations and transition rules

Every manufacturer also needs a person responsible for regulatory compliance (PRRC). Manufacturers outside the EU must appoint an EU authorised representative (Article 11).

Legacy MDD devices: under Regulation (EU) 2023/607, Class III devices with an MDD certificate that was valid on 26 May 2021 may stay on the market until 31 December 2027 if the device still complies with the MDD, has no significant change in design or intended purpose, presents no unacceptable risk to health or safety, the manufacturer had an MDR-compliant QMS in place by 26 May 2024, and a formal application was lodged with a Notified Body by 26 May 2024 with a written agreement signed by 26 September 2024. See the MDR transition timeline.

Regulatory status (November 2026): on 16 December 2025 the European Commission proposed a targeted revision of the MDR and IVDR. It is still a proposal before the European Parliament and Council. The requirements on this page reflect the MDR as currently in force; this page will be updated if the amendment is adopted.

Borderline cases

What Are Common Class III Classification Mistakes?

  • Calling every implant Class III. Most implants are Class IIb under Rule 8. They become Class III only through a specific condition such as heart contact, absorption or a named device type.
  • Missing an ancillary medicine. A coating with a medicinal substance that supports the device moves it to Class III under Rule 14, even when the base device is lower risk.
  • Overlooking animal-derived materials. Collagen, gelatin and other non-viable animal tissue derivatives usually trigger Rule 18.
  • Classifying software on its own when it drives a device. Software that controls a Class III device takes the device’s class.
  • Assuming MDD classes still apply. The MDR moved several device types up to Class III, including joint replacements, spinal implants, breast implants and surgical meshes.
  • Planning equivalence without data access. For Class III, claiming equivalence to another manufacturer’s device usually requires a contract giving full access to its technical documentation.

Class IIb vs Class III

What Is the Difference Between Class IIb and Class III?

Both classes need a Notified Body, but Class III adds a review of every device file, a clinical investigation for all devices and an SSCP. For the full side-by-side view of all four classes, see Class I vs IIa vs IIb vs III.

RequirementClass IIbClass III
Notified BodyRequiredRequired
Technical documentation reviewAt least one representative device per generic device group (Annex IX, Section 2.3)Every device (Annex IX, Chapter II)
Clinical investigationRequired for implantable Class IIb devices (Article 61(4)); otherwise based on the clinical evaluationRequired for all Class III devices unless an Article 61(4) to 61(6) exemption applies
Clinical evaluation consultation (CECP)Only active devices intended to administer or remove a medicinal product (Rule 12)All implantable Class III devices (Article 54)
Summary of safety and clinical performance (SSCP)Implantable Class IIb devices onlyAll Class III devices (Article 32)
PSURAt least annually (Article 86)At least annually, submitted to the Notified Body (Article 86)

Lower-risk classes: Class I is low risk and self-declared (except Is, Im and Ir), and Class IIa is medium risk with a Notified Body required.

Work with I3CGLOBAL

Class III CE Marking Consulting from I3CGLOBAL

I3CGLOBAL has completed 300+ CE certifications worldwide, with offices in India, Europe and the USA. Tell us about your device and we will suggest the right route.

Our MDR CE marking case studies include Class III projects such as an insulin pump, a defibrillator and an intrauterine device classified under Rule 14.

  • Classification and conformity route
  • Technical documentation and GSPR checklist
  • Clinical evaluation, CER and PMCF
  • Notified Body submission and review responses

Request your proposal

Share your device details and we will prepare an MDR proposal.

Request an MDR QuoteContact Us

FAQs

Class III Medical Device: Frequently Asked Questions

Is Class 3 the same as Class III?

Yes. The MDR writes the class in Roman numerals as Class III. Class 3 is the same class written with an Arabic number. Both refer to the highest-risk class under Annex VIII of EU MDR 2017/745.

Does every Class III device need a clinical investigation?

Usually yes. Article 61(4) requires clinical investigations for implantable and Class III devices. Limited exemptions exist, for example some modified devices from the same manufacturer, some equivalent devices with full data access, and certain well-established technologies listed in Article 61(6).

What is the clinical evaluation consultation procedure (CECP)?

CECP is the Article 54 procedure for Class III implantable devices. The Notified Body sends its clinical evaluation assessment report to an expert panel, which may give a scientific opinion. The Notified Body must consider that opinion before issuing the certificate.

How often must a Class III PSUR be updated?

At least once a year. Under Article 86, Class III manufacturers update the periodic safety update report annually and submit it to their Notified Body for review. When the EUDAMED vigilance module becomes mandatory, submission will take place through EUDAMED.

Can software be a Class III medical device?

Yes. Under Rule 11, software is Class III when the information it provides is used for decisions that may cause death or an irreversible deterioration of a person’s health. Software that drives a Class III device also takes the device’s class.

Can a Class III device be self-certified?

No. A Class III device always needs a Notified Body. The Notified Body assesses the quality management system and the technical documentation of every Class III device before the CE certificate is issued.

How long does Class III CE marking take?

There is no fixed timeline. The longest steps are usually the clinical investigation, compiling the technical documentation and the Notified Body review of the QMS and every device file. For implantable Class III devices, the expert panel must decide within 21 days whether to give an opinion and deliver it within 60 days (Annex IX, Section 5.1). Overall duration depends on the device, the clinical data available and Notified Body capacity.

Is EU Class III the same as US FDA Class III?

No. The EU and US systems classify devices with different rules. In the EU, Class III follows the Annex VIII rules of MDR 2017/745 and leads to Notified Body assessment. In the US, Class III under 21 CFR Part 860 generally requires a Premarket Approval (PMA). A device can be Class III in one system and a lower class in the other, so each market needs its own classification.

Does a Class III manufacturer outside the EU need an EU Authorised Representative?

Yes. Article 11 requires every manufacturer not established in an EU Member State to appoint a single EU Authorised Representative before placing a device on the EU market, whatever the class. The representative is named on the label and must have its own person responsible for regulatory compliance.

Do all Class III devices need an implant card?

No. Article 18 applies to implantable devices only. A Class III device that is not implanted, such as Class III software or an IVF culture medium, does not need an implant card. Implantable Class III devices need one unless they are on the exemption list (sutures, staples, screws, plates and similar components).